Article

Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment

2016-11-17

Abstract excerpt

<h4>ABSTRACT</h4> The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer syndromes can lead to reductions in morbidity and mortality through targeted risk management options. Additionally, advances in gene sequencing tech...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b391655c-d434-55a2-b1f4-0a1065c72a2e
DOI: 10.1101/088252

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessmentDOI 10.1101/088252Read

Design and validation of a next generation sequencing assay for hereditary breast and ovarian cancerSemantic proximity Read

Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.Semantic proximity Read

Inherited Cancer in the Age of Next-Generation Sequencing.Semantic proximity Read

Human Mutation special issue on innovations in genomic diagnostics.Semantic proximity Read

The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory.Semantic proximity Read

Cancer Genetic Predisposition and Clinical Applications-A Narrative Review on Germline Genetic Testing, High-Risk Cancer Surveillance and Management.Semantic proximity Read

Sequencing approaches in hereditary cancer testing: strengths, limitations and future directionsSemantic proximity Read

Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.Semantic proximity Read

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.Semantic proximity Read

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.Semantic proximity Read

Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A ReviewSemantic proximity Read

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.Semantic proximity Read